ProfileGDS4132 / 220404_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 39% 43% 29% 34% 31% 42% 31% 28% 31% 32% 35% 29% 32% 32% 23% 29% 31% 32% 31% 35% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101102.17739
GSM201543Muscle PCOS pioglitazone 121105.42143
GSM201544Muscle PCOS pioglitazone 16172.792429
GSM201545Muscle PCOS pioglitazone 20193.116234
GSM201829Muscle PCOS pioglitazone 23181.612131
GSM201830Muscle PCOS pioglitazon 25111442
GSM201831Muscle PCOS pioglitazone 27173.927931
GSM201832Muscle PCOS pioglitazone 3169.682228
GSM201833Muscle PCOS pioglitazone 4173.431131
GSM201834Muscle PCOS pioglitazone 8176.845132
GSM201835Muscle PCOS after pioglitazone 10272.973435
GSM201836Muscle PCOS after pioglitazone 12260.276529
GSM201837Muscle PCOS after pioglitazone 16265.913532
GSM201838Muscle PCOS after pioglitazone 20269.885632
GSM201839Muscle PCOS after pioglitazone 23247.85723
GSM201840Muscle PCOS after pioglitazone 25267.288329
GSM201841Muscle PCOS after pioglitazone 27262.179331
GSM201842Muscle PCOS after pioglitazone 3263.724432
GSM201843Muscle PCOS after pioglitazone 4275.315731
GSM201844Muscle PCOS after pioglitazone 8282.77235